293 related articles for article (PubMed ID: 11985000)
1. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes].
Christiansen AL; Madsbad S
Ugeskr Laeger; 2002 Apr; 164(15):2025-8. PubMed ID: 11985000
[TBL] [Abstract][Full Text] [Related]
2. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
Raskin P
Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
[TBL] [Abstract][Full Text] [Related]
3. [Thus to avoid complications of diabetes. To combine early].
MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732409
[No Abstract] [Full Text] [Related]
4. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents.
Goodarzi MO; Bryer-Ash M
Diabetes Obes Metab; 2005 Nov; 7(6):654-65. PubMed ID: 16219009
[TBL] [Abstract][Full Text] [Related]
5. [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].
Hermann LS; Melander A
Lakartidningen; 1999 Dec; 96(50):5616-9. PubMed ID: 10643226
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone maleate + metformin hydrochloride extend: review of an emerging compound.
Cheng AY; Josse RG
Expert Opin Investig Drugs; 2009 Sep; 18(9):1365-73. PubMed ID: 19642952
[TBL] [Abstract][Full Text] [Related]
7. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
8. [Metformin--its regimen and effects].
Shiba T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():382-8. PubMed ID: 12387022
[No Abstract] [Full Text] [Related]
9. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].
Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
Ter Arkh; 2010; 82(8):34-41. PubMed ID: 20873243
[TBL] [Abstract][Full Text] [Related]
10. Sitagliptin/metformin (Janumet) for type 2 diabetes.
Med Lett Drugs Ther; 2007 Jun; 49(1262):45-7. PubMed ID: 17541377
[No Abstract] [Full Text] [Related]
11. [Differential therapy with oral antidiabetic drugs].
Sachse G
Z Gesamte Inn Med; 1993 Mar; 48(3):127-9. PubMed ID: 8475635
[TBL] [Abstract][Full Text] [Related]
12. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
[TBL] [Abstract][Full Text] [Related]
13. Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial.
Douek IF; Allen SE; Ewings P; Gale EA; Bingley PJ;
Diabet Med; 2005 May; 22(5):634-40. PubMed ID: 15842521
[TBL] [Abstract][Full Text] [Related]
14. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
15. The addition of acarbose to insulin lispro reduces acute glycaemic responses in patients with type-2 diabetes.
Hermanns N; Burkert A; Haak T
Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):310-4. PubMed ID: 15216448
[TBL] [Abstract][Full Text] [Related]
16. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
[TBL] [Abstract][Full Text] [Related]
17. Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled Type 2 diabetes.
Stewart MW; Cirkel DT; Furuseth K; Donaldson J; Biswas N; Starkie MG; Phenekos C; Hamann A
Diabet Med; 2006 Oct; 23(10):1069-78. PubMed ID: 16978370
[TBL] [Abstract][Full Text] [Related]
18. [Metabolism control in overweight type 2 diabetics. High metformin dosage brings more].
MMW Fortschr Med; 2001 Nov; 143(44):56. PubMed ID: 11732400
[No Abstract] [Full Text] [Related]
19. [What dosage of antidiabetics?].
Soudaei S
Tidsskr Nor Laegeforen; 2005 Jun; 125(11):1538. PubMed ID: 15940337
[No Abstract] [Full Text] [Related]
20. [Insulin sparing and metabolic control with metformin-insulin combination].
Isnard F
Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
